loader2
Partner With Us NRI

Global Health Ltd

Company details

436.70
459.40
391.05
487.75
6M Return 0.00%
1Y Return 9.89%
Mkt Cap.(Cr) 12,249.35
Volume 19,814
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 19,814

Open Free Demat Account Online with ICICIDIRECT

FINANCIALS

Sales

Operating Profit

Profit after Tax

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after Tax

PE

Debt/Equity

P BV

COMPARISION

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 1,616.02 Cr FV: 2.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 41.01 -16,297.57
LAST 3M 16,935.72 -4,368.10
LAST 6M 40,997.71 72,693.54
LAST 12M 176,172.92 -109,962.90

INFORMATION

Stock PE (TTM)

62.48

Promoter Holding

33.08%

Book Value

78.9018

ROCE

14.05%

ROE

13.09%

Description

  • Global Health Limited was incorporated as `Global Health Private Limited` on August 13, 2004 at New Delhi, India as a Private Limited Company under the Companies Act, 1956. The Company converted into a Public Limited Company, passed by Shareholders at the EGM held on July 31, 2021 and consequently, name of the Company was changed to `Global Health Limited` dated August 11, 2021 issued by the RoC. The Company was founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon. The Company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urologoly. Under the "Medanta" brand, it has a network of 5 hospitals currently in operation including, Gurugram, Indore, Ranchi, Lucknow and Patna and one hospital in Noida, which is under construction. As at June 30, 2022, the Company provide healthcare services in over 30 medical specialties and is engaged over 1,300 doctors led by experienced department heads and, spanning an area of 4.7 million sq. ft., their operational hospitals have 2,467 installed beds to serve Indian and international patients. In November 2009, the Company opened its flagship hospital in Gurugram. In 2015, its subsidiary, Global Health Patliputra Private Limite (GHPPL), entered into a Concession Agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on public-private partnership at Patna. In 2019, it commenced operations of new hospital at Lucknow. In 2020, Patna hospital`s outpatient department facility was launched and the inpatient department facility of its Patna hospital was inaugurated in October 2021, which commenced operations during year 2022. The Company has taken in-house facility and operate pharmacies at its Gurugram, Lucknow, Indore and Ranchi hospitals as well as launched an outpatient department pharmacy at South Delhi clinic in year 2021 and launched outpatient department pharmacy at South Delhi clinic at Patna hospital in year 2022. As at June 30, 2022, it had 200 installed beds and employed over 50 doctors across key specialties such as neuroscience and cardiac sciences. Patna hospital had 228 installed beds and employed over 125 doctors as at June 30, 2022 and is designed to accommodate over 500 beds. In the Board Meeting dated 25 January 2021, the Board of Directors of the Holding Company have approved capital raising comprising of fresh issue and offer for sale of equity shares by the existing shareholders through an Initial Public Offering (IPO) The Company came out with a public issue during November, 2022 by raising Rs. 2205.57 crores through fresh issue amounting to Rs. 500 crores and offer for sale amounting to Rs. 1705.57 crores.

Registered Address

Medanta-Mediclinic, E-18 Defence Colony, New Delhi, New Delhi, 110024

Email : compliance:medanta.org
Website : http://www.medanta.org

Registrar

KFin Techologies Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 543654
NSE Code : MEDANTA
Book Closure Date (Month) :
BSE Group : B
ISIN : INE474Q01031

ICICIdirect Global Health Ltd FAQ

You can buy Global Health Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Global Health Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jan 25, 2023 04:01 PM the closing price of Global Health Ltd was ₹ 456.75.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jan 25, 2023 04:01 PM, the market cap of Global Health Ltd stood at ₹ 12,249.35.
The latest PE ratio of Global Health Ltd as of Jan 25, 2023 04:01 PM is 62.48
The latest PB ratio of Global Health Ltd as of Jan 25, 2023 04:01 PM is 0.17
The 52-week high of Global Health Ltd is ₹ 487.75 while the 52-week low is ₹ 391.05

Download Our App

market app
market app